Caption Management, LLC Biocryst Pharmaceuticals Inc Call Options Transaction History

Caption Management, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $91,273 - $150,059	22,100 Added 44.2%	72,100 $445,000
Q4 2023 Feb 14, 2024	SELL	$4.98 - $6.77 $62,250 - $84,625	-12,500 Reduced 20.0%	50,000 $299,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $419,375 - $495,000	62,500 New	62,500 $442,000
Q1 2023 May 15, 2023	SELL	$7.94 - $11.84 $317,600 - $473,600	-40,000 Reduced 50.0%	40,000 $333,000
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $105,000 - $142,000	10,000 Added 14.29%	80,000 $918,000
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $138,075 - $312,900	-17,500 Reduced 20.0%	70,000 $741,000
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $375,700 - $642,200	32,500 Added 59.09%	87,500 $1.42 Million
Q4 2021 Feb 11, 2022	SELL	$11.18 - $15.46 $3.07 Million - $4.25 Million	-275,000 Reduced 83.33%	55,000 $764,000
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $1.29 Million - $1.6 Million	-90,800 Reduced 21.58%	330,000 $4.74 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $1.62 Million - $2.94 Million	170,800 Added 68.32%	420,800 $6.66 Million
Q1 2021 May 17, 2021	BUY	$7.37 - $13.61 $1.84 Million - $3.4 Million	250,000 New	250,000 $2.54 Million
Q1 2020 May 15, 2020	SELL	$1.6 - $4.11 $589,920 - $1.52 Million	-368,700 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.59 - $3.45 $586,233 - $1.27 Million	368,700 New	368,700 $1.27 Million

257

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.57B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.